Clinical trial
Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to…
NCT00362115 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00362115 |
|---|---|
| Title | Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension |
| Official title | A Phase 2, Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study of the Efficacy, Safety and Tolerability of TAK-491 in Subjects With Mild to Moderate Uncomplicated Essential Hypertension |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Azilsartan Medoxomil, Olmesartan, Placebo |
| Enrollment | 449 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Aug 9, 2006 |
| Last update posted | Apr 19, 2011 |
| Countries | Argentina, Mexico, Peru, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: